Recommended Articles
View All
India’s external affairs minister lists 10 reasons the world should take note — Budget 2023
Feb 2, 2023 IST2 Min(s) Read
The A to Z of FM Sitharaman's Budget 2023 — alphabetically yours
Feb 1, 2023 IST6 Min(s) Read
Nirmala Sitharaman’s big capex push a welcome step, but funding could prove a challenge
Feb 1, 2023 IST3 Min(s) Read
Old vs new tax regime after Budget 2023 — Check which is better for you
Feb 1, 2023 IST4 Min(s) Read
CNBC-TV18 has learnt that the USFDA has started inspecting Sun Pharma’s Halol facility. As the economy has opened up as well as travel has restarted, it is normal for the US regulator to start inspecting plants which are overseas, and India has one of the largest number of plants outside of the US that supply pharmaceuticals to the latter.
The USFDA is expected to have started the inspection of the facility today with three auditors. The Halol plant was inspected by USFDA in December 2019 after which they were issued an official action indicated (OAI) in March 2020 -- an OAI means that the USFDA expects more corrective actions to be undertaken by the company for that particular facility.
Watch the accompanying video of CNBC-TV18’s Ekta Batra for more details.
Catch all stock market updates here